Intelligence · Clinical Pipeline
Teva Pharma Pipeline
All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.
- Programs
- 126
Quick answer
Teva Pharma has 126 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Talampanel
Teva Pharma GmbH
ALS
1 trial -
Talampanel
Teva Pharma GmbH
Glioblastoma Multiforme
2 trials -
Talampanel
Teva Pharma GmbH
Epilepsy
1 trial -
Talampanel
Teva Pharma GmbH
Amyotrophic Lateral Sclerosis
1 trial -
Tiotropium HFA BAI 4.5 mcg
Teva Pharma GmbH
COPD
1 trial -
Tiotropium HFA BAI 5 mcg
Teva Pharma GmbH
Chronic Obstructive Pulmonary Disease
1 trial -
Tizanidine (sublingual or oral)
Teva Pharma GmbH
Muscle Spasticity
1 trial -
armodafinil
Teva Pharma GmbH
Schizophrenia
2 trials -
autologous mesenchymal stem cells implantation
Teva Pharma GmbH
Tibial Fracture
1 trial -
bendamustine
Teva Pharma GmbH
Hodgkin Lymphoma
2 trials -
bendamustine
Teva Pharma GmbH
Multiple Myeloma
1 trial -
bendamustine and rituximab
Teva Pharma GmbH
Non-Hodgkin's Lymphoma
1 trial -
cytarabine
Teva Pharma GmbH
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
1 trial -
desogestrel/ethinyl estradiol and ethinyl estradiol
Teva Pharma GmbH
Hemostasis
1 trial -
edratide
Teva Pharma GmbH
Systemic Lupus Erythematosus
1 trial -
etiprednol dicloacetate
Teva Pharma GmbH
Crohn's Disease
1 trial -
fremanezumab
Teva Pharma GmbH
Interstitial Cystitis
1 trial -
glatiramer acetate
Teva Pharma GmbH
Crohns Disease
1 trial -
glatiramer acetate 20 mg
Teva Pharma GmbH
Relapse-Remitting Multiple Sclerosis
1 trial -
glatiramer acetate 20 mg
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
1 trial -
glatiramer acetate with minocycline
Teva Pharma GmbH
Relapse Remitting Multiple Sclerosis
1 trial -
infusion of MYOCET
Teva Pharma GmbH
Cerebral Lymphoma B Cell Refractory
1 trial -
inhaled delta-8-THC 300mcg or 600mcg per dose
Teva Pharma GmbH
Cancer
1 trial -
laquinimod 0.3
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
1 trial -
lestaurtinib
Teva Pharma GmbH
Polycythemia Vera
1 trial -
methylprednisolone
Teva Pharma GmbH
Multiple Sclerosis (MS)
1 trial -
rasagiline mesylate
Teva Pharma GmbH
Multiple System Atrophy
1 trial -
sublingual tizanidine 12 mg
Teva Pharma GmbH
Spasticity
1 trial -
talampanel
Teva Pharma GmbH
Dyskinesias
1 trial -
tbo-filgrastim
Teva Pharma GmbH
Neutropenia
1 trial
Frequently asked questions
How many pipeline programs does Teva Pharma have?
126 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs